Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis.

[1]  D. Oreopoulos,et al.  Biocompatibility of peritoneal dialysis solutions. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  E. Stylianou,et al.  Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. , 1994, Kidney international.

[3]  A. Donker,et al.  Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis? , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  N. Topley,et al.  In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  B. Lindholm,et al.  Tryptophan and its metabolites in patients on continuous ambulatory peritoneal dialysis and following renal transplantation. , 1994, Nephrology, Dialysis and Transplantation.

[6]  R. Krediet,et al.  Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. , 1993, The Journal of infectious diseases.

[7]  T. Liberek,et al.  Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. , 1993, Nephron.

[8]  A. Wieslander,et al.  Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. , 1993, Clinical nephrology.

[9]  J. Westwick,et al.  Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. , 1993, The American journal of pathology.

[10]  A. Douvdevani,et al.  The Effect of Peritoneal Dialysis Fluid on the Release of Il-113 and Tnfa by Macrophages/Monocytes , 1993 .

[11]  A. Donker,et al.  Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  A. Donker,et al.  In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. , 1993, Clinical nephrology.

[13]  T. Liberek,et al.  Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. , 1993, Journal of the American Society of Nephrology : JASN.

[14]  M. Davies,et al.  Cytokine Networks in Continuous Ambulatory Peritoneal Dialysis: Interactions of Resident Cells during Inflammation in the Peritoneal Cavity , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[15]  W. Luttmann,et al.  Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1β and TNFα , 1993 .

[16]  A. Donker,et al.  Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. , 1992, Kidney international.

[17]  T. Hla,et al.  Human cyclooxygenase-2 cDNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Oreopoulos,et al.  Toxicity of osmotic solutes on human mesothelial cells in vitro. , 1992, Kidney international.

[19]  N. Topley,et al.  Biocompatibility of Peritoneal Dialysis Fluids , 1992, The International journal of artificial organs.

[20]  E. Köttgen,et al.  Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle. , 1992, American journal of nephrology.

[21]  R. Espinosa,et al.  axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase , 1991, Molecular and cellular biology.

[22]  A. Wieslander,et al.  Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. , 1991, Kidney international.

[23]  G. FitzGerald,et al.  Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  S. Lewis,et al.  Host Defense Mechanisms in the Peritoneal Cavity of Continuous Ambulatory Peritoneal Dialysis Patients: First of Two Parts , 1991 .

[25]  M. Davies,et al.  In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  E. Köttgen,et al.  Leukotriene B4 and tumor necrosis factor release from leukocytes: effect of peritoneal dialysate. , 1991, Nephron.

[27]  N. Topley,et al.  Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  E. Stylianou,et al.  Isolation, culture and characterization of human peritoneal mesothelial cells. , 1990, Kidney international.

[29]  T. Kooistra,et al.  Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. , 1990, Blood.

[30]  J. Knowlden,et al.  The assessment of relative surface hydrophobicity as a factor involved in the activation of human polymorphonuclear leukocytes by uropathogenic strains of Escherichia coli. , 1989, Biochimica et biophysica acta.

[31]  H. Verbrugh,et al.  Cytotoxic Effects of Commercial Continuous Ambulatory Peritoneal Dialysis (CAPD) Fluids and of Bacterial Exoproducts on Human Mesothelial Cells in Vitro , 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[32]  J. Cook,et al.  Viability measurements in mammalian cell systems. , 1989, Analytical biochemistry.

[33]  A. Sheil,et al.  Peritoneal morphology on maintenance dialysis. , 1989, American journal of nephrology.

[34]  D. Lloyd,et al.  The effect of dialysate on peritoneal phagocyte oxidative metabolism. , 1988, Kidney international.

[35]  J. Dobbie,et al.  Phosphatidylcholine synthesis by peritoneal mesothelium: its implications for peritoneal dialysis. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  K. Resch,et al.  Enhancement of eicosanoid synthesis in mouse peritoneal macrophages by the organic mercury compound thimerosal. , 1988, Prostaglandins.

[37]  J H Korn,et al.  Structure and expression of cDNA and genes for human interferon‐beta‐2, a distinct species inducible by growth‐stimulatory cytokines. , 1986, The EMBO journal.

[38]  D. Lloyd,et al.  Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function. , 1986, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  B. Gallimore,et al.  Cytotoxicity of commercial peritoneal dialysis solutions towards peritoneal cells of chronically uremic mice. , 1986, Nephron.

[40]  N. Di Paolo,et al.  Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. , 1986, Nephron.

[41]  M. Redinbaugh,et al.  Adaptation of the dye-binding protein assay to microtiter plates. , 1985, Analytical biochemistry.

[42]  F. N. Miller,et al.  The peritoneal microcirculation , 1985 .

[43]  K. Nolph,et al.  Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury. , 1983, Kidney international.

[44]  M. Claeys,et al.  Arachidonic acid metabolism by cultured mesothelial cells. Different transformations of exogenously added and endogenously. , 1982, Biochimica et biophysica acta.

[45]  J. Dobbie,et al.  Ultrastructural Studies on the Peritoneum with Special Reference to Chronic Ambulatory Peritoneal Dialysis , 1981, Scottish medical journal.

[46]  A. Duwe,et al.  Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro , 1981, Infection and immunity.

[47]  M. Claeys,et al.  Prostaglandin production by cultured mesothelial cells. , 1981, Archives internationales de pharmacodynamie et de therapie.

[48]  K. Nolph,et al.  The peritoneal dialysis system. , 1979, Contributions to nephrology.

[49]  Bornstein Mb,et al.  Reconstituted rattail collagen used as substrate for tissue cultures on coverslips in Maximow slides and roller tubes. , 1958, Laboratory investigation; a journal of technical methods and pathology.

[50]  M. Bornstein.  Reconstituted rattail collagen used as substrate for tissue cultures on coverslips in Maximow slides and roller tubes. , 1958, Laboratory investigation; a journal of technical methods and pathology.